Speaking at a hearing in the European Union (EU), the european Parliament, Brussels, on Tuesday, the European Medicines Agency’s (EMA) Head, Guido Rasi said an initial authorization for the united states pharmaceutical company Gilead Sciences Remdesivir as a corona virus treatment could be given in the next few days, according to Reuters.
Rasi has noted that: “It could be that a market condition, the authorization may be issued in the next few days.”
The reaction of the Market
The common currency was little inspired by the positive news, such as the EUR/USD turns positive, and seeks to break down below the 1.08 handle. The place of the trades at 1.0811, a decrease of 0.06% on the day.